Reaction
Microsporidia Infection reporting signals
As of the last recalculation, Microsporidia Infection appears in 351 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is POSACONAZOLE DELAYED-RELEASE (PRR 314.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Posaconazole Delayed-Release | 50 | 314.7 | 316.1 |
| Alemtuzumab | 64 | 239.8 | 240.6 |
| Posaconazole | 50 | 212.6 | 213.3 |
| Basiliximab | 37 | 208.4 | 209.1 |
| Everolimus Tablets | 34 | 133.0 | 133.3 |
| Fludarabine Phosphate | 69 | 129.3 | 129.5 |
| Calcitriol Capsules 0.25 Mcg | 37 | 122.2 | 122.5 |
| Calcitriol Capsules 0.5 Mcg | 37 | 122.2 | 122.5 |
| Calcitriol | 37 | 120.8 | 121.1 |
| Tacrolimus Ointment 0.1% | 132 | 100.1 | 100.2 |
| Tacrolimus Extended-Release Capsules | 132 | 99.9 | 100.0 |
| Voriconazole Injection | 32 | 96.1 | 96.2 |
| Anti-Thymocyte Globulin (Rabbit) | 12 | 91.3 | 91.4 |
| Tacrolimus | 136 | 83.4 | 83.5 |
| Pravastatin Sodium | 23 | 73.6 | 73.7 |
| Voriconazole | 33 | 71.0 | 71.1 |
| Valganciclovir Hydrochloride Powder, | 14 | 70.9 | 70.9 |
| Clindamycin | 29 | 65.9 | 66.0 |
| Mycophenolate Mofetil Hydrochloride | 104 | 64.0 | 64.0 |
| Mycophenolate Mofetil | 103 | 63.2 | 63.3 |
| Clindamycin Phosphate | 29 | 56.0 | 56.1 |
| Ceftriaxone Sodium | 32 | 54.3 | 54.4 |
| Mycophenilic Acid | 17 | 51.1 | 51.1 |
| Valganciclovir | 14 | 45.8 | 45.9 |
| Valganciclovir Hydrochloride | 14 | 45.8 | 45.9 |
| Everolimus | 34 | 43.8 | 43.8 |
| Valacyclovir | 28 | 43.2 | 43.2 |
| Ibrutinib | 50 | 42.6 | 42.7 |
| Insulin Aspart | 38 | 38.1 | 38.1 |
| Cannabidiol | 9 | 23.4 | 23.4 |